Lv2
190 积分 2024-05-28 加入
reciprocal assistance
Abstract 5736: AZD9592: An EGFR-cMET bispecific antibody-drug conjugate (ADC) targeting key oncogenic drivers in non-small-cell lung cancer (NSCLC) and beyond
8小时前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
20天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
20天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
21天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
2个月前
已完结
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2个月前
已完结
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
2个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
2个月前
已完结
Advances and resistance adaptation in BTK-targeted therapy for B-cell malignancies
2个月前
已完结
Treatment of chronic cough: P2X3 receptor antagonists and beyond
2个月前
已完结
皖公网安备34019202002308
